Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/08820139.2020.1773850 http://scihub22266oqcxt.onion/10.1080/08820139.2020.1773850 32482134!?!32482134 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32482134&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Immunol+Invest 2021 ; 50 (1): 92-100 Nephropedia Template TP {{tp|p=32482134|t=2021. NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19 |pdf=|usr=}}{{32482134}} gab.com Text NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19 JO: Immunol Invest http://www.kidney.de/pget.php?&tw=1&pmid=32482134 #FOAvip COVID-19 exhibits a non-yet elucidated heterogeneity dominated by mild form of the illness. Nevertheless, mortality is frequent among patients with a delayed innate immune response that suddenly exacerbates during the second week after admission leading to a lethal over inflammation. Therefore, this rapid and unpredictable deterioration requires timely prediction of COVID-19 refractoriness and critical illness. The two biomarkers readily available in routine laboratories, blood lymphocytes and neutrophil counts, are expected to provide an accurate clinical tool to incline reasonable medication and care because lymphopenia marks immune exhaustion while neutrophilia demonstrates the immunological exuberation. Meanwhile, combining the two parameters as a Neutrophil-to-lymphocyte ratio (NLR) helps to constitute a powerful predictive and prognostic nomogram. This scoring tool allows clinicians to stratify COVID-19 severities on admission and guide early interventions to accelerate recovery and shorten the course of disease in order to alleviate the shortage of medical resources and reduce mortality. Twit Text FOAVip NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19 ????Immunol Invest http://www.kidney.de/pget.php?&tw=1&pmid=32482134 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32482134 #FOAvip English Wikipedia <ref>{{Cite pmid|32482134}}</ref> NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19 #MMPMID32482134 Kerboua KE Immunol Invest 2021[Jan]; 50 (1): 92-100 PMID32482134show ga COVID-19 exhibits a non-yet elucidated heterogeneity dominated by mild form of the illness. Nevertheless, mortality is frequent among patients with a delayed innate immune response that suddenly exacerbates during the second week after admission leading to a lethal over inflammation. Therefore, this rapid and unpredictable deterioration requires timely prediction of COVID-19 refractoriness and critical illness. The two biomarkers readily available in routine laboratories, blood lymphocytes and neutrophil counts, are expected to provide an accurate clinical tool to incline reasonable medication and care because lymphopenia marks immune exhaustion while neutrophilia demonstrates the immunological exuberation. Meanwhile, combining the two parameters as a Neutrophil-to-lymphocyte ratio (NLR) helps to constitute a powerful predictive and prognostic nomogram. This scoring tool allows clinicians to stratify COVID-19 severities on admission and guide early interventions to accelerate recovery and shorten the course of disease in order to alleviate the shortage of medical resources and reduce mortality. |*Lymphocyte Count[MESH] |*Nomograms[MESH] |Biomarkers/blood[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/mortality/*pathology[MESH] |Cost-Benefit Analysis[MESH] |Critical Illness[MESH] |Humans[MESH] |Lymphocytes/*cytology/immunology[MESH] |Lymphopenia/immunology[MESH] |Neutrophils/*cytology/immunology[MESH] |SARS-CoV-2[MESH]NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in C(epmc).pdf DeepDyve Pubget Overpricing